by The Roskamp Institute | Nov 5, 2020 | News
By Laura Finaldi, Heraldtribune.com 11/5/20 A Sarasota company that researches and treats diseases of the mind is on track to receive, and then make available to local patients, a drug that experts say can be an effective treatment for Alzheimer’s disease. The...
by The Roskamp Institute | Aug 28, 2020 | News
The Roskamp Institute, jointly with The Open University UK, offers a doctoral degree in Neuroscience and is pleased to announce the program’s 14th graduate Charis Ringland. Charis joined the Institute as a Ph.D. student in January 2017. While she worked on a number of...
by The Roskamp Institute | Jul 5, 2020 | News
Florida Red Tide has been destroying marine life and adversely affecting coastal Floridians for decades, with little understanding of its potential health risks to those in our community. The Roskamp Institute is currently conducting a clinical study on the potential...
by The Roskamp Institute | May 6, 2020 | News
For over two decades Roskamp Institute scientists have studied the causes and potential cures for neurological disorders such as Alzheimer’s Disease (AD), including the link between environmental agents and increased risk for AD and other brain conditions. So when...
by The Roskamp Institute | Mar 6, 2020 | News
Sarasota, Fla.— New data from a clinical trial of Alzheimer’s Disease using a drug called Nilvadipine identified by researchers at the Roskamp Institute show that patients with very mild (very early stage) Alzheimer’s disease show less cognitive decline over an...
by The Roskamp Institute | Feb 17, 2020 | News
Disappointingly, and somewhat surprisingly, two drugs aimed at halting alzheimer’s disease by reducing levels of the amyloid protein in the brain have failed in a late-stage clinical trial. The clinical trial sponsored by Washington University, called DIAN-TU,...